Skip to content
Vulnerability Intelligence

CVE-2023-38950

HighExploitedPublic exploit

A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

Published Aug 3, 2023 · Updated Jul 9, 2026

Key Facts

Patch immediately
  • CVE-2023-38950 is a high-severity vulnerability (CVSS 7.5 v3.1) affecting Biotime (Zkteco).
  • It is exploited in the wild, listed in CISA KEV, Industry KEV feed, CIRCL KEV, ENISA EUVD since May 2, 2025. Public exploit code is available.
  • EPSS estimates a 92% probability of exploitation in the next 30 days.
  • Fixed versions are available, including Biotime 9.0.1.
  • Brandefense priority: patch immediately, because it is listed as exploited in the wild.

CVSS v3.1

7.5

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

EPSS (30-day exploit likelihood)

92%

Higher than 99.8% of all scored CVEs

Exploited in the wild

Yes

4 catalog listings

Public exploit code

Available

Proof-of-concept or weaponized module

Get the full CVE-2023-38950 brief as a PDF

Every affected product and fixed release, exploitation status and a first 24 hours response checklist, emailed within minutes.

Description

A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.

Known-Exploited Catalog Listings

CatalogAddedRemediation dueRansomware use
CISA KEVMay 19, 2025Jun 9, 2025Not reported
Industry KEV feedMay 2, 2025Jun 9, 2025Not reported
CIRCL KEVMay 19, 2025Jun 9, 2025Not reported
ENISA EUVDMay 19, 2025n/aNot reported

Required action: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

Affected Products

1 affected entries in total
ProductAffected versionsFixed in
BiotimeZktecoSee advisory9.0.1

Patched Releases

Biotime

9.0.1

Timeline

  1. Publicly disclosed

    Aug 3, 2023

  2. Added to Industry KEV feed

    May 2, 2025

  3. Added to CISA KEV

    May 19, 2025

  4. Added to CIRCL KEV

    May 19, 2025

  5. Added to ENISA EUVD

    May 19, 2025

  6. Last updated

    Jul 9, 2026

Weakness Type

  • CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

References

4 more references in the full CVE brief

FAQ

Common Questions.

Is CVE-2023-38950 Running On Your Attack Surface?

Brandefense maps vulnerabilities like this one to your internet-facing assets and tells you exactly where to patch.

Request A Demo